Your browser doesn't support javascript.
loading
5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation.
Hsu, Wan-Tseng; Tseng, Ya-Hsuan; Jui, Hsiang-Yiang; Kuo, Chen-Chin; Wu, Kenneth K; Lee, Chii-Ming.
Afiliación
  • Hsu WT; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Tseng YH; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Jui HY; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Kuo CC; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
  • Wu KK; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan; College of Life Sciences, National Tsing Hua University, Hsin-Chu, Taiwan.
  • Lee CM; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan. Electronic address: 111361@ntuh.gov.tw.
J Mol Cell Cardiol ; 158: 101-114, 2021 09.
Article en En | MEDLINE | ID: mdl-34087195
ABSTRACT

AIMS:

Myocardial infarction (MI) remains a major cause of heart failure. 5-Methoxytryptophan (5-MTP), a 5-methoxyindole metabolite of L-tryptophan, exerts anti-inflammatory and antifibrotic effects, but MI impairs the biosynthesis of cardiac 5-MTP. Therefore, we evaluated the effect of exogenous 5-MTP administration on rescuing post-MI cardiac injury. METHODS AND

RESULTS:

After a detailed pharmacokinetic analysis of 5-MTP, Sprague Dawley rats that had undergone left anterior descending coronary artery ligation received intraperitoneal administration of either 17 mg/kg 5-MTP or saline at 0.5 and 24 h after MI. Cardiac systolic function, infarction size, and fibrosis were evaluated using echocardiography, triphenyltetrazolium chloride staining, and Masson trichrome staining, respectively. Myocardial apoptosis was analyzed by staining for caspase-3 and cardiac troponin I. 5-MTP treatment decreased the infarct area and myocardial apoptosis; attenuated systolic dysfunction and left ventricular dilatation; and reduced cardiomyocyte hypertrophy, myocardial fibrosis, and infarct expansion. Crucially, 5-MTP alleviated oxidative stress by preserving mitochondrial antioxidant enzymes and downregulating reactive oxygen species-generating NADPH oxidase isoforms and endothelin-1. Consequently, 5-MTP-treated MI rat hearts exhibited lower levels of chemokines and cytokines, namely interleukin (IL)-1ß, IL-18, IL-6, C-C motif chemokine ligand (CCL)-2, and CCL5, accompanied by reduced infiltration of CD11b+ cells and CD4+ T cells. Notably, 5-MTP protected against H2O2-induced damage in HL-1 cardiomyocytes and human umbilical vein endothelial cells in vitro.

CONCLUSION:

5-MTP prevented post-MI cardiac injury by promoting mitochondrial stabilization and controlling redox imbalance. This cytoprotective effect ameliorated macrophage and T-cell infiltration, thus reducing the infarct size, attenuating fibrosis, and restoring myocardial function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triptófano / Estrés Oxidativo / Inmunidad / Infarto del Miocardio Tipo de estudio: Etiology_studies Límite: Animals / Female / Humans Idioma: En Revista: J Mol Cell Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triptófano / Estrés Oxidativo / Inmunidad / Infarto del Miocardio Tipo de estudio: Etiology_studies Límite: Animals / Female / Humans Idioma: En Revista: J Mol Cell Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Taiwán